Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease

被引:62
作者
Antzoulatos, Eleni [1 ,2 ]
Jakowec, Michael W. [3 ,4 ]
Petzinger, Giselle M. [3 ,4 ]
Wood, Ruth I. [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Neurosci Grad Program, Los Angeles, CA 90033 USA
[3] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA
[4] Univ So Calif, Dept Biokinesiol, Los Angeles, CA 90033 USA
关键词
Parkinson's disease; Striatum; Substantia nigra; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Motor behavior; Sex characteristics testosterone; Estrogen; GENDER-DIFFERENCES; SUBSTANTIA-NIGRA; ANIMAL-MODELS; TIME-COURSE; MICE; ESTROGEN; RATS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 6-HYDROXYDOPAMINE; NEUROPROTECTION;
D O I
10.1016/j.pbb.2010.03.009
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Sex differences in Parkinson's disease (PD) have been reported in humans and rodent models, with a higher incidence in men and increased severity in male rodents. The current study examined sex differences and the effects of gonadal steroid hormones in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned mouse model of PD. Male (n = 51) and female (n = 50) mice were gonadectomized and received physiologic replacement with testosterone or estrogen (Experiment 1), or no hormones (Experiment 2). Two weeks later, mice received either MPTP (10 mg/kg per day for 5 days) or saline. Higher doses killed female mice. Mice were tested one week after MPTP for motor performance using rotarod, pole and gait tests. In hormone-treated mice, males significantly outperformed females in all three tests (p<0.05). Compared with females, males had a greater overall rotarod performance (ORP: 1317.1 +/- 98.3 vs. 988.1 +/- 95.6), descended a pole faster (7.1 +/- 0.6 vs. 9.6 +/- 0.7 s), and had longer stride lengths (hindlimb 7.3 +/- 0.1 vs. 6.8 +/- 0.1 cm). By contrast, ovariectomized female mice receiving saline outperformed castrated males on the rotarod (1296.6 +/- 83.3 vs. 811.2 +/- 113.7, p<0.05) and descended a pole faster (9.7 +/- 2.0 vs. 15.6 +/- 1.9s, p<0.05). MPTP significantly impaired ORP (p<0.05) in hormone-treated males (703.7 +/- 65.5) and females (432.8 +/- 88.6, p<0.05). After MPTP, stride length was selectively decreased in males (hindlimb 6.6 +/- 0.1 cm, p<0.05), and pole test performance was unimpaired in either sex. After gonadectomy, MPTP did not decrease motor performance in males (p>0.05) but significantly reduced ORP in females (975.9 +/- 110.3 vs. saline females, p<0.05). Our results show that small, chronic doses of MPTP produce subtle, sexually-dimorphic impairments in motor performance, but without a loss of tyrosine hydroxylase-positive neurons in the substantia nigra. In gonadectomized mice, this sex difference is reversed. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 52 条
  • [1] Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice
    Alvarez-Fischer, Daniel
    Henze, Carmen
    Strenzke, Corinna
    Westrich, Jan
    Ferger, Boris
    Hoeglinger, Guenter U.
    Oertel, Wolfgang H.
    Hartmann, Andreas
    [J]. EXPERIMENTAL NEUROLOGY, 2008, 210 (01) : 182 - 193
  • [2] Gait dynamics in mouse models of Parkinson's disease and Huntington's disease
    Amende I.
    Kale A.
    McCue S.
    Glazier S.
    Morgan J.P.
    Hampton T.G.
    [J]. Journal of NeuroEngineering and Rehabilitation, 2 (1)
  • [3] American College of Sports Medicine, 2006, POS STAT SEN HEAR AB
  • [4] EFFECTS OF CASTRATION AND SILASTIC IMPLANTS OF TESTOSTERONE ON INTERMALE AGGRESSION IN MOUSE
    BARKLEY, MS
    GOLDMAN, BD
    [J]. HORMONES AND BEHAVIOR, 1977, 9 (01) : 32 - 48
  • [5] Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case-control study
    Benedetti, MD
    Maraganore, DM
    Bower, JH
    McDonnell, SK
    Peterson, BJ
    Ahlskog, JE
    Schaid, DJ
    Rocca, WA
    [J]. MOVEMENT DISORDERS, 2001, 16 (05) : 830 - 837
  • [6] Toxin-induced models of Parkinson's disease
    Bové J.
    Prou D.
    Perier C.
    Przedborski S.
    [J]. NeuroRX, 2005, 2 (3): : 484 - 494
  • [7] Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson's disease
    Cass, WA
    Peters, LE
    Smith, MP
    [J]. BRAIN RESEARCH, 2005, 1034 (1-2) : 153 - 161
  • [8] Effects of riluzole on combined MPTP+3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice
    Diguet, E
    Fernagut, PO
    Scherfler, C
    Wenning, G
    Tison, F
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (05) : 613 - 631
  • [9] Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system
    Dluzen, DE
    [J]. JOURNAL OF NEUROCYTOLOGY, 2000, 29 (5-6): : 387 - 399
  • [10] Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>3.0.CO